Department of Plastic and Reconstructive Surgery, St. Josef Hospital, Vienna, Austria.
Department of Plastic, Aesthetic and Reconstructive Surgery, Wilhelminen Hospital, Vienna, Austria.
Int Wound J. 2018 Dec;15(6):914-920. doi: 10.1111/iwj.12944. Epub 2018 Jun 29.
Hypertrophic scar formation because of surgical procedures is associated with higher levels of pain, a lower quality of life, and poor cosmetic outcome and requires more resources in follow-up management. An octenidine-based hydrogel has been shown to modulate immunological function in an in vitro wound model, suggesting an improved scar formation. In this prospective, randomised, observer-blinded, and intra-patient-controlled study, 45 patients who underwent abdominoplasty or mastectomy with transverse rectus abdominis muscle (TRAM) flap reconstruction were given both a standard postoperative wound dressing on one wound side and an octenidine-based hydrogel with transparent film dressing, covered with standard postoperative dressing on the other side. Four instances of hypertrophia were reported in the gel side versus 12 in the standard dressing side. Visual Analogue Scale (VAS) pain scores taken during postoperative dressing changes showed reduced scores on the gel side at all time points. Vancouver Scar Scale (VSS) scores showed improvement in the gel side at 3, 6, and 12 months postoperatively. Skin distensibility measured using a cutometer showed significantly improved measures in gel-treated wounds, similar to measures of healthy skin. Trans-epidermal water loss (TEWL), measured using a tewameter, showed improved values on the gel side soon after surgery, with both the control and the gel side normalising after approximately 6 months. The octenidine-based wound dressing demonstrates improved wound healing associated with a lower incidence of hypertrophic scar formation.
手术引起的增生性瘢痕形成与更高水平的疼痛、更低的生活质量和较差的美容效果有关,并且在后续管理中需要更多的资源。一种基于奥替尼啶的水凝胶已被证明可以在体外伤口模型中调节免疫功能,提示改善了疤痕形成。在这项前瞻性、随机、观察者盲法和患者内对照研究中,45 名接受腹部整形术或乳房切除术联合横行腹直肌肌皮瓣(TRAM)重建的患者,一侧伤口使用标准术后伤口敷料,另一侧伤口使用含奥替尼啶的水凝胶和透明薄膜敷料,再覆盖标准术后敷料。在凝胶侧报告了 4 例增生,而在标准敷料侧报告了 12 例。在术后敷料更换期间进行的视觉模拟评分(VAS)疼痛评分显示,在所有时间点,凝胶侧的评分均降低。温哥华瘢痕量表(VSS)评分显示,术后 3、6 和 12 个月时凝胶侧有所改善。使用皮肤弹性计测量的皮肤伸展性显示,凝胶处理的伤口有明显改善的测量值,与健康皮肤的测量值相似。使用经皮水分流失仪(tewameter)测量的经皮水分流失(TEWL)显示,手术后不久凝胶侧的数值改善,而对照组和凝胶侧在大约 6 个月后均恢复正常。基于奥替尼啶的伤口敷料显示出改善的伤口愈合,伴有较低的增生性瘢痕形成发生率。